Body Composition

Cardiac remodeling caused by cold acclimation is reversible with rewarming in zebrafish (Danio rerio).

Thursday, August 31, 2023 - 10:00 PM

Comparative biochemistry and physiology. Part A, Molecular & integrative physiology; 09/01/2023(AN 37302568); ISSN: 1531-4332MEDLINE Ultimate

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month lo...

Thursday, August 31, 2023 - 10:00 PM

Diabetes, obesity & metabolism; 09/01/2023(AN 37246799); ISSN: 1463-1326MEDLINE Ultimate

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month lo...

Thursday, August 31, 2023 - 10:00 PM

Diabetes, obesity & metabolism; 09/01/2023(AN 37246799); ISSN: 1463-1326MEDLINE Ultimate

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month lo...

Thursday, August 31, 2023 - 10:00 PM

Diabetes, obesity & metabolism; 09/01/2023(AN 37246799); ISSN: 1463-1326MEDLINE Ultimate

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month lo...

Thursday, August 31, 2023 - 10:00 PM

Diabetes, obesity & metabolism; 09/01/2023(AN 37246799); ISSN: 1463-1326MEDLINE Ultimate

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month lo...

Thursday, August 31, 2023 - 10:00 PM

Diabetes, obesity & metabolism; 09/01/2023(AN 37246799); ISSN: 1463-1326MEDLINE Ultimate

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month lo...

Thursday, August 31, 2023 - 10:00 PM

Diabetes, obesity & metabolism; 09/01/2023(AN 37246799); ISSN: 1463-1326MEDLINE Ultimate

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month lo...

Thursday, August 31, 2023 - 10:00 PM

Diabetes, obesity & metabolism; 09/01/2023(AN 37246799); ISSN: 1463-1326MEDLINE Ultimate

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month lo...

Thursday, August 31, 2023 - 10:00 PM

Diabetes, obesity & metabolism; 09/01/2023(AN 37246799); ISSN: 1463-1326MEDLINE Ultimate

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month lo...

Thursday, August 31, 2023 - 10:00 PM

Diabetes, obesity & metabolism; 09/01/2023(AN 37246799); ISSN: 1463-1326MEDLINE Ultimate